TAU IMMUNOTHERAPY FOR ALZHEIMER’S (Review Article)

Alzheimer's is a tormenting disease that progressively destroys a person's cognition. Researchers have toiled long and hard to find a cure or slow the course of this disease. Therapies have mainly targeted the two hallmarks of Alzheimer's pathophysiology: amyloid and tau protein. This paper sheds light on the new developments in the field of immunotherapy aimed against tau protein, particularly in comparison to the thus far futile efforts of targeting amyloid. Tau targeting immunotherapy is emerging as a promising therapeutic option.